Exercise extreme caution in Remdesivir use: Centre
The Hindu
In revised advisory, Health Ministry says it is not suggested for patients with mild symptoms
The Health Ministry said on Monday that Remdesivir, a drug currently used in treatment of COVID-19, can be used only in select moderate/ severe hospitalised patients on supplemental oxygen, as it is a reserve drug approved under the Emergency Use Authorization based on limited scientific evidence globally. In a revised advisory, it said the drug is not indicated in patients with mild symptoms who are in home care/ COVID Care Centres and that doctors are advised to exercise extreme caution in using this reserve/ experimental/ emergency use authorisation drug. The Ministry said the advisory is aimed at stopping the misuse of this experimental drug, which is relatively expensive, has limited availability and has a potential to harm. To stop the misuse of the drug, the Ministry has recommended that Remdesivir must be advised by senior faculty members/ specialists directly involved in a patient’s care.More Related News

“Judicial time is a valuable public resource. Every frivolous or misconceived invocation of constitutional jurisdiction results in diversion of time from genuinely deserving litigants,” said the Madurai Bench of the Madras High Court while imposing a cost of ₹50,000 on a man from Theni district who filed a petition with an unusual prayer: permission to conduct daily protests till the ‘World War’ ends.












